West Bancorporation announced a net income of $11.6 million for Q3 2026, a 24.8% increase compared to Q3 2025, driven by higher net interest income and improved efficiency. The company declared a quarterly dividend of $0.26 per share payable in November. Strong credit quality, margin expansion, and disciplined expense management supported profitability. The bank maintains a solid balance sheet with no nonaccrual loans and expects continued growth amid favorable market conditions.
West Bancorporation's Q3 2026 financial results provide context for readers following financials. As of Oct 29, 2026 19:11 WIB, 96 of 142 priced Financials-sector US stocks on Pluang rose while 42 fell. Notable movers include BTBT at USD 0.92 with a 1-day change of -4.68% and Pluang order activity of 83% Sell / 17% Buy, and BBVA at USD 23.95 with 0% Sell / 100% Buy activity and a typical hold time of 83 days.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
